[go: up one dir, main page]

SG10201804146XA - Methods for collecting and using placenta cord blood stem cells - Google Patents

Methods for collecting and using placenta cord blood stem cells

Info

Publication number
SG10201804146XA
SG10201804146XA SG10201804146XA SG10201804146XA SG10201804146XA SG 10201804146X A SG10201804146X A SG 10201804146XA SG 10201804146X A SG10201804146X A SG 10201804146XA SG 10201804146X A SG10201804146X A SG 10201804146XA SG 10201804146X A SG10201804146X A SG 10201804146XA
Authority
SG
Singapore
Prior art keywords
isolated
stem cells
cord blood
blood stem
collecting
Prior art date
Application number
SG10201804146XA
Inventor
Naoko Takebe
Original Assignee
Hli Cellular Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hli Cellular Therapeutics Llc filed Critical Hli Cellular Therapeutics Llc
Publication of SG10201804146XA publication Critical patent/SG10201804146XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Dentistry (AREA)

Abstract

METHODSFOR COLLECTING AND USING PI,ACENTA CORD BLOOD STEM CELLS An ínnovative method of cotlecting cord blood stem cells ftrcm an isolated mammalian non- exsanguinated or partially exsanguinated placeufa by placcntal perfusion is described. Placental perfr¡sion can include perfusing the isolated placenfa with a pulsatile flow of perfusion solution, for example, gsing a pulsatile orperistalfic pufnp or device. The stem cells can thcn be isolated fiom tlte perfusate. The perftrsion solution can include an ariticoagr¡lant. The isolated mammaliân placenfa necd not be treated with an anticoagulant prior to perfusitrg. The isolated plãcenta can be free from an anticoagulant prior to pcrfising. Figure I
SG10201804146XA 2006-05-11 2007-05-11 Methods for collecting and using placenta cord blood stem cells SG10201804146XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79973406P 2006-05-11 2006-05-11

Publications (1)

Publication Number Publication Date
SG10201804146XA true SG10201804146XA (en) 2018-06-28

Family

ID=38694487

Family Applications (3)

Application Number Title Priority Date Filing Date
SG201103291-9A SG171669A1 (en) 2006-05-11 2007-05-11 Methods for collecting and using placenta cord blood stem cells
SG2013040373A SG191608A1 (en) 2006-05-11 2007-05-11 Methods for collecting and using placenta cord blood stem cells
SG10201804146XA SG10201804146XA (en) 2006-05-11 2007-05-11 Methods for collecting and using placenta cord blood stem cells

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SG201103291-9A SG171669A1 (en) 2006-05-11 2007-05-11 Methods for collecting and using placenta cord blood stem cells
SG2013040373A SG191608A1 (en) 2006-05-11 2007-05-11 Methods for collecting and using placenta cord blood stem cells

Country Status (14)

Country Link
US (4) US8329468B2 (en)
EP (4) EP3603390B1 (en)
JP (1) JP5260499B2 (en)
KR (1) KR101514078B1 (en)
CN (2) CN101483998A (en)
BR (1) BRPI0711599B8 (en)
CA (3) CA2909053C (en)
ES (1) ES2581738T3 (en)
IL (1) IL195241A (en)
MX (1) MX2008014426A (en)
MY (1) MY157763A (en)
SG (3) SG171669A1 (en)
WO (1) WO2007133665A2 (en)
ZA (1) ZA200809770B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2671355T3 (en) 2005-12-29 2018-06-06 Anthrogenesis Corporation Placental stem cell populations
US9944900B2 (en) * 2006-01-18 2018-04-17 Hemacell Perfusion Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells
US8673547B2 (en) * 2007-03-08 2014-03-18 Hemacell Perfusion, Inc. Method for isolation of afterbirth derived cells
KR20220025141A (en) 2008-08-20 2022-03-03 셀룰래리티 인코포레이티드 Improved cell composition and methods of making the same
WO2010021756A1 (en) 2008-08-22 2010-02-25 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
CN103540566A (en) * 2008-11-14 2014-01-29 路易斯维尔大学研究基金会有限公司 Methods and compositions for long term hematopoietic repopulation
JP5869342B2 (en) 2008-11-19 2016-02-24 アンスロジェネシス コーポレーション Amnion-derived adherent cells
WO2011002926A2 (en) * 2009-07-01 2011-01-06 The General Hospital Corporation Isolated adult cells, artificial organs,rehabilitated organs, research rools, organ encasements, organ perfusion systems, and methods for preparing and utilizing the same
JP2013523823A (en) 2010-04-08 2013-06-17 アントフロゲネシス コーポレーション Treatment of sarcoidosis using placental stem cells
WO2011140241A2 (en) 2010-05-04 2011-11-10 The General Hospital Corporation Methods and compositions for preserving tissues and organs
AR093183A1 (en) 2010-12-31 2015-05-27 Anthrogenesis Corp INCREASE IN THE POWER OF PLACENTA MOTHER CELLS USING MODULATING RNA MOLECULES
CN102757935A (en) * 2011-04-29 2012-10-31 北京汉氏联合生物技术有限公司 Method for extracting hematopoietic stem cell from placental chorionic tissue and construction method of hematopoietic stem cell
TWI602570B (en) 2011-06-01 2017-10-21 安瑟吉納西斯公司 Treatment of pain using placental stem cells
US10190092B2 (en) 2011-08-11 2019-01-29 Robert A. Dracker Procurement of placental stem cells
WO2013049670A1 (en) * 2011-09-28 2013-04-04 Epic Sciences, Inc. Method for optimizing the collection of rare cells in blood
US10179152B2 (en) * 2013-10-03 2019-01-15 Celularity, Inc. Therapy with cells from human placenta and hematopoietic cells
EP3068432A4 (en) * 2013-11-15 2017-04-19 Anthrogenesis Corporation Compositions comprising human placental perfusate cells, subpopulations thereof, and their uses
CN103756965B (en) * 2014-01-27 2016-04-06 山东省齐鲁干细胞工程有限公司 A kind of method of lavation hemopoietic stem cell from placenta
CN103789262A (en) * 2014-02-17 2014-05-14 宁波普莱森特生物科技有限公司 Preparation method and preservation method of clinical application-level placental hematopoietic stem cells
WO2015138832A1 (en) 2014-03-13 2015-09-17 The General Hospital Corporation Devices and methods to improve and assess viability of human livers
FR3035407B1 (en) 2015-04-23 2022-06-17 Francais Du Sang Ets METHOD FOR PRESERVING CELLS, TISSUES OR ORGANS IN HYPOTHERMIA
WO2018039294A1 (en) 2016-08-24 2018-03-01 Arthrex, Inc. Tissue use for repair of injury
WO2018232110A1 (en) 2017-06-14 2018-12-20 The General Hospital Corporation High subzero cryopreservation
CN108531454A (en) * 2018-04-09 2018-09-14 孔五 The purposes of Cord blood regenerated particle and composition in treating brain degenerative disease
WO2019232268A1 (en) 2018-05-30 2019-12-05 Mustafa Korkut Uygun Cryopreservation of tissues and organs
CN113395972A (en) * 2018-11-30 2021-09-14 细胞结构公司 Placenta-derived allogeneic CAR-T cells and uses thereof
US11511017B2 (en) 2019-03-12 2022-11-29 Arthrex, Inc. Ligament reconstruction

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1337139A4 (en) 2000-10-27 2004-12-29 Cornell Res Foundation Inc Alteration of plant nitrate and oxalic acid concentration
EP2206772A3 (en) * 2000-12-06 2010-08-04 Robert J. Hariri Method of collecting placental stem cells
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP2336299A1 (en) * 2001-02-14 2011-06-22 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
ES2559031T3 (en) * 2001-02-14 2016-02-10 Anthrogenesis Corporation Renewal and repopulation of decellularized tissues and cadaveric organs by stem cells
KR20110036114A (en) * 2002-02-13 2011-04-06 안트로제네시스 코포레이션 Embryonic-like Stem Cells Derived from Postpartum Mammal Placenta and Their Uses and Methods
US7060494B2 (en) * 2002-04-09 2006-06-13 Reliance Life Sciences Pvt. Ltd. Growth of human Mesenchymal Stem Cells (hMSC) using umbilical cord blood serum and the method for the preparation thereof
US20050118715A1 (en) * 2002-04-12 2005-06-02 Hariri Robert J. Modulation of stem and progenitor cell differentiation, assays, and uses thereof
US7498171B2 (en) * 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
BRPI0407427A (en) * 2003-02-13 2006-01-24 Anthrogenesis Corp Method to treat a patient and to treat myelodysplasia
CN1548529A (en) 2003-05-09 2004-11-24 中国人民解放军军事医学科学院基础医 A method for isolating human placental mesenchymal stem cells
PL2322599T3 (en) * 2003-06-27 2015-10-30 Depuy Synthes Products Inc Postpartum cells derived from umbilical cord tissue and methods of making and using the same for repair and regeneration of soft tissue
EP1694853A1 (en) * 2003-12-18 2006-08-30 Cerestar Holding B.V. Oxidation of carbohydrates by means of peroxidases and nitroxy radicals
WO2006088867A2 (en) * 2005-02-15 2006-08-24 Medistem Laboratories, Incorporated Method for expansion of stem cells
AU2006304277B2 (en) * 2005-10-13 2012-07-05 Celularity Inc. Immunomodulation using placental stem cells
ES2671355T3 (en) * 2005-12-29 2018-06-06 Anthrogenesis Corporation Placental stem cell populations
KR100783711B1 (en) 2006-01-06 2007-12-07 삼성전자주식회사 Metal compound and organic electroluminescent device comprising same
US9944900B2 (en) * 2006-01-18 2018-04-17 Hemacell Perfusion Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells

Also Published As

Publication number Publication date
CA3103505C (en) 2023-07-04
US20160220618A1 (en) 2016-08-04
CN105087490A (en) 2015-11-25
US20130108591A1 (en) 2013-05-02
CA2909053C (en) 2021-02-09
US20200138872A1 (en) 2020-05-07
JP5260499B2 (en) 2013-08-14
EP4094578A1 (en) 2022-11-30
BRPI0711599B1 (en) 2021-03-02
EP3603390B1 (en) 2023-12-20
CN101483998A (en) 2009-07-15
US20090123437A1 (en) 2009-05-14
JP2009536824A (en) 2009-10-22
SG171669A1 (en) 2011-06-29
CA2652051A1 (en) 2007-11-22
KR20090026158A (en) 2009-03-11
CA2652051C (en) 2015-12-08
KR101514078B1 (en) 2015-04-22
ZA200809770B (en) 2010-03-31
WO2007133665A2 (en) 2007-11-22
EP2023717A4 (en) 2009-12-16
CA3103505A1 (en) 2007-11-22
IL195241A (en) 2014-02-27
EP2023717A2 (en) 2009-02-18
MX2008014426A (en) 2009-02-18
MY157763A (en) 2016-07-15
WO2007133665A3 (en) 2008-12-18
SG191608A1 (en) 2013-07-31
CA2909053A1 (en) 2007-11-22
US9364585B2 (en) 2016-06-14
US10548926B2 (en) 2020-02-04
IL195241A0 (en) 2009-08-03
BRPI0711599B8 (en) 2021-07-27
EP2023717B1 (en) 2016-04-13
BRPI0711599A8 (en) 2017-04-04
ES2581738T3 (en) 2016-09-07
EP3603390A1 (en) 2020-02-05
EP3114931A1 (en) 2017-01-11
US8329468B2 (en) 2012-12-11
BRPI0711599A2 (en) 2011-11-16

Similar Documents

Publication Publication Date Title
SG10201804146XA (en) Methods for collecting and using placenta cord blood stem cells
MX2017015530A (en) Post-partum mammalian placenta, its use and placental stem cells therefrom.
WO2002064755A3 (en) Post-partum mammalian placenta, its use and placental stem cells therefrom
NZ612801A (en) Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
CN202958590U (en) In-vitro liver low-temperature continuous pulse type machine perfusion storage device
WO2010096821A3 (en) Method for ice-free cryopreservation of tissue
RS53841B1 (en) TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSES AND INTERMEDIATE CELLS KILLED ORIGINATING IN HUMAN PLACENTA
DK1888742T3 (en) Liver Stem Cells
SG195252A1 (en) Methods and uses for ex vivo tissue culture systems
MX340043B (en) CONSERVATIVE COMPOSITION OF ORGANS AND USES.
RU2012105922A (en) DIFFERENTIATION OF HUMAN EMBRYONAL STEM CELLS
BR112012010750A2 (en) human germ stem cell storage system
WO2009137829A3 (en) Directed stem cell recruitment
WO2006107850A3 (en) Preventing rejection of transplanted tissue using regulatory t cells
WO2008055224A3 (en) Lithium stimulation of cord blood stem cell proliferation and growth factor production
GB2429717A (en) Cell preservation method
WO2012121521A3 (en) Method of oocyte cryopreservation using antifreeze protein
WO2014197798A3 (en) Transplantation device and method of use
CN102217589A (en) Perfusion preservation device for liver
WO2011060357A3 (en) Engineered xenogeneic cells for repair of biological tissue
WO2013023212A3 (en) Procurement of placental stem cells
JP2010166901A5 (en)
RU2011103549A (en) PREDATOR OF ARTIFICIAL KIDNEY AND METHOD OF ITS PRODUCTION
WO2007082203A3 (en) In-situ preservation (isp) bridge method and solution for non-heart beating donors
CN202617886U (en) Special watering equipment used after transplanting of salt pines and alkali pines